Maurizio Paoloni
Overview
Explore the profile of Maurizio Paoloni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
193
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salpini R, Piermatteo L, Torre G, DAnna S, Khan S, Duca L, et al.
Int J Infect Dis
. 2023 Nov;
138:1-9.
PMID: 37944585
Objectives: Here we investigate Hepatitis D virus (HDV)-prevalence in Italy and its fluctuations over time and we provide an extensive characterization of HDV-infected patients. Methods: The rate of HDV seroprevalence...
2.
Carubbi F, Salvati L, Alunno A, Maggi F, Borghi E, Mariani R, et al.
Sci Rep
. 2021 Mar;
11(1):4863.
PMID: 33649408
The coronavirus 2019 disease (COVID-19) is characterised by a heterogeneous clinical presentation, a complex pathophysiology and a wide range of imaging findings, depending on disease severity and time course. We...
3.
Salpini R, Battisti A, Piermatteo L, Carioti L, Anastasiou O, Gill U, et al.
Emerg Microbes Infect
. 2020 Apr;
9(1):928-939.
PMID: 32312174
Increasing evidences suggest that HBsAg-production varies across HBV-genotypes. HBsAg C-terminus plays a crucial role for HBsAg-secretion. Here, we evaluate HBsAg-levels in different HBV-genotypes in HBeAg-negative chronic infection, the correlation of...
4.
Di Maio V, Cento V, Lenci I, Aragri M, Rossi P, Barbaliscia S, et al.
Liver Int
. 2017 Jan;
37(4):514-528.
PMID: 28105744
Background & Aims: Despite the excellent efficacy of direct-acting antivirals (DAA) reported in clinical trials, virological failures can occur, often associated with the development of resistance-associated substitutions (RASs). This study...
5.
Polilli E, Sozio F, Di Stefano P, Sciacca A, Ursini T, Paoloni M, et al.
AIDS Patient Care STDS
. 2016 Oct;
30(10):471-475.
PMID: 27749107
Undiagnosed cases of HIV infection in developed countries are estimated at 20-30% of individuals living with HIV. Web-based strategies may represent a new approach to easier, wider, and unrestricted access...
6.
Polilli E, Tontodonati M, Flacco M, Ursini T, Striani P, Di Giammartino D, et al.
Infection
. 2015 Sep;
44(1):85-91.
PMID: 26363567
Purpose: Available estimates of the prevalence of chronic HCV infection in Italy are quite conflicting, varying from 1.5 to 22.5%, with an apparent north to south gradient. As Direct Acting...
7.
Salpini R, Colagrossi L, Bellocchi M, Surdo M, Becker C, Alteri C, et al.
Hepatology
. 2014 Nov;
61(3):823-33.
PMID: 25418031
Unlabelled: Hepatitis B virus (HBV) reactivation during immunosuppression can lead to severe acute hepatitis, fulminant liver failure, and death. Here, we investigated hepatitis B surface antigen (HBsAg) genetic features underlying...
8.
Piccolo D, Di Cesare A, Fargnoli M, Paoloni M, Vecchiotti S, Peris K
Eur J Dermatol
. 2008 Jun;
18(4):459-60.
PMID: 18573723
No abstract available.